{"anticipatedPostingDate":"2009-11","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"description":"Number of patients who were alive and free of disease (malignancy) at 24 months after transplant.","groups":[{"description":"All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.","id":"OG000","title":"Evaluable Patients"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"24 Months Post transplant","title":"Number of Patients Who Were Disease-free and Alive at 24 Months","type":"SECONDARY","unitOfMeasure":"Participants"}